25 May 2013
Keywords: somaxon, gets, american, rights, biotie, oral, nalmefene
Article | 22 November 2004
San Diego, USA-based Somaxon Pharmaceuticals says it has licensed the North American rights to oral nalmefene hydrochloride from Finnish drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
15 November 2004
24 May 2013
© 2013 thepharmaletter.com